全文获取类型
收费全文 | 69571篇 |
免费 | 8319篇 |
国内免费 | 2327篇 |
专业分类
耳鼻咽喉 | 175篇 |
儿科学 | 1359篇 |
妇产科学 | 514篇 |
基础医学 | 8168篇 |
口腔科学 | 1128篇 |
临床医学 | 6278篇 |
内科学 | 11366篇 |
皮肤病学 | 532篇 |
神经病学 | 1695篇 |
特种医学 | 2422篇 |
外国民族医学 | 97篇 |
外科学 | 5373篇 |
综合类 | 11631篇 |
现状与发展 | 17篇 |
预防医学 | 3151篇 |
眼科学 | 709篇 |
药学 | 7148篇 |
45篇 | |
中国医学 | 3483篇 |
肿瘤学 | 14926篇 |
出版年
2024年 | 292篇 |
2023年 | 1475篇 |
2022年 | 2802篇 |
2021年 | 3907篇 |
2020年 | 3343篇 |
2019年 | 2883篇 |
2018年 | 2721篇 |
2017年 | 3152篇 |
2016年 | 3411篇 |
2015年 | 3576篇 |
2014年 | 4748篇 |
2013年 | 5703篇 |
2012年 | 4154篇 |
2011年 | 4456篇 |
2010年 | 3588篇 |
2009年 | 3344篇 |
2008年 | 3281篇 |
2007年 | 3498篇 |
2006年 | 3086篇 |
2005年 | 2682篇 |
2004年 | 2218篇 |
2003年 | 1763篇 |
2002年 | 1455篇 |
2001年 | 1266篇 |
2000年 | 1011篇 |
1999年 | 818篇 |
1998年 | 712篇 |
1997年 | 670篇 |
1996年 | 586篇 |
1995年 | 452篇 |
1994年 | 420篇 |
1993年 | 356篇 |
1992年 | 354篇 |
1991年 | 286篇 |
1990年 | 240篇 |
1989年 | 203篇 |
1988年 | 208篇 |
1987年 | 169篇 |
1986年 | 148篇 |
1985年 | 133篇 |
1984年 | 120篇 |
1983年 | 91篇 |
1982年 | 85篇 |
1981年 | 78篇 |
1980年 | 78篇 |
1979年 | 57篇 |
1978年 | 38篇 |
1977年 | 31篇 |
1976年 | 20篇 |
1975年 | 23篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
CT增强扫描在评价NSCLC血管生成中的临床意义 总被引:3,自引:3,他引:0
目的 探讨非小细胞肺癌 (NSCLC)血管内皮生长因子 (VEGF)的表达水平与CT增强程度的关系 ,从影像学角度评价肿瘤血管生成在肺癌诊断、治疗及淋巴结转移中的临床价值。方法 对 30例NSCLC病人进行动态螺旋CT扫描 (SCT) ,测量病灶增强幅度 ,并利用免疫组化技术检测VEGF。对病灶增强值、VEGF阳性表达及淋巴结转移情况进行统计学分析。结果 30例肺癌病人CT增强值均数为 (36 .2 8± 6 .41 )HU ,VEGF阳性表达 2 1例 ,阴性表达 9例。VEGF在中晚期的阳性表达高于早期病人 (Ρ<0 .0 5) ,淋巴结转移组高于非淋巴结转移组 (Ρ <0 .0 5) ;癌灶增强值与VEGF阳性表达、肿瘤分期及淋巴结转移亦呈正相关。结论 NSCLC的CT增强程度能够反映肿瘤的血管生成 ,并与淋巴结转移密切相关 ,有助于肺癌的诊断、TNM分期 ,而且可以从肿瘤分子生物学行为方面补充目前肺癌分期方法的不足 相似文献
72.
50例冠心病某些生化基础观测的临床诊断意义 总被引:1,自引:0,他引:1
对50例冠心病患者进行某些生化基础观测,发现冠心病肾阴虚与糖耐量减低有关,肾阳虚患者尿17-羟低於正常;而冠心病标证有其生化基础,与甘油三酯增高有密切相关。 相似文献
73.
74.
观察了大鼠实验性肺移植术后急性排斥反应的病理改变。异系间移植术后2d,移植肺内小血管及支气管周围出现单核细胞浸润。4d上述细胞浸润波及肺泡壁,导致肺泡壁增厚,肺内小静脉系及毛细血管管腔变窄,血流不畅。术后6d,血液循环严重障碍处,肺泡完全坏死,环抱素A可使上述排斥反应得到明显抑制。 相似文献
75.
Jin S. Lee Herman I. Libshitz William K. Murphy Diane Jeffries Waun K. Hong 《Investigational new drugs》1990,8(3):299-304
Summary Thirty-one patients with stage IIIB or IV non-small cell lung cancer (NSCLC) were treated with intravenous 10-EdAM on a weekly basis. The starting dose was 80 mg/m2, with subsequent doses adjusted depending on evidence of toxicity. There were 20 men and 11 women with a median age of 58 years (range, 33–75). Response was evaluated in 30 patients, 5 with evaluable but not measurable tumors and 25 with measurable indicator lesions. There were no complete remissions; 3 patients achieved partial remission. Nine patients had a minor response, 6 showed no change, and 12 had progressive disease. Median survival for all 31 patients was 43 weeks (range, 12–65+). During the first 3-week period, the 10-EdAM dose was reduced or withheld in 19 patients (because of stomatitis in 12, SGPT elevation in 3, skin rash in 2, and granulocytopenia in 2), escalated in 11 patients, and unchanged in 1 patient. A mean of 34–88 mg/m2of 10-EdAM (median, 50) was given per week during the first 5-week period. Myelotoxicity was infrequent and there was no significant nephrotoxicity. Considering the modest side effects of this treatment and the conservative dose-modification schedule which mandated substantial dose reductions, we conclude that 10-EdAM is a promising antitumor agent for NSCLC. 相似文献
76.
Endotoxin-induced uveitis (EIU) in the rat: A study of inflammatory and immunological mechanisms 总被引:2,自引:0,他引:2
Endotoxin-induced uveitis (EIU) can be produced by systemic injection of endotoxin (ET). It is not clear yet why exclusive ocular involvement occurs in this model. To clarify this question and to establish the sequence of inflammatory events, EIU was induced in Lewis rats by footpad injection of Salmonella ET. Ocular inflammatory response (anterior chamber cells and proteins), aqueous inflammation mediators (thromboxane B2, prostaglandin E2, leukotriene B4 and substance P) and MHC class 2 (Ia) antigen expression in the ciliary body were monitored for 72 hours. Thromboxane B2 was detected early in the aqueous humor, peaking already 1 hour after ET injection. Prostaglandin E2 & leukotriene B4 peaks and a second peak of thromboxane B2 were recorded 18 hours after ET-injection, at the time of maximal ocular inflammation. MHC-class 2 expression was first detected in the ciliary body stroma at the vascular level 6 hours after ET injection and was massively expressed in the ciliary body epithelium at 18 and 72 hours. It is hypothetized that ciliary body endothelium is particularly sensitive to the effect of ET and is the site of thrombocyte adherence. Vascular damage leads in succession to cellular infiltration, release of inflammation mediators and disruption of blood-ocular barrier. MHC-class 2 expression is a secondary phenomenon and is probably at the origin of additional tissue damage from immune effector mechanisms. 相似文献
77.
曹之言 《重庆医科大学学报》1988,(4)
作者报道28例经手术及病理证实的肺部囊性病变,其中21例为先天性,7例为后天性.x线表现可分为:①单发气囊腔.②多发性气囊腔.③单发液囊腔.④单或多发液气囊腔,内有液平面.⑤肺隔离症.讨论了形成机理以及与肺结核,肺脓肿,肺癌,转移性肺肿瘤,肺包虫囊肿等的x线鉴别诊断 相似文献
78.
Wallin C.-J. B.; Jacobson S. H.; Leksell L. G. 《Nephrology, dialysis, transplantation》1996,11(11):2269-2275
It has been postulated that patients with chronic renal failure,even in the absence of cardiopulmonary symptoms, accumulateinterstitial pulmonary fluid, which is removed by haemodialysis.To test this hypothesis we used the indocyanine green (ICG)-heavywater double indicator dilution method to measure lung water,cardiac output, and central blood volume in relation to haemodialysis.Ten uraemic patients, without cardiopulmonary symptoms, wereinvestigated at the beginning and end, and 2 h after, a regulardialysis session. A group of 18 surgical patients about to undergoelective abdominal surgery served as controls. Despite normalgas exchange, central blood volume, and cardiac output at thestart of dialysis the mean (SD) lung water was significantlyhigher than in the control group [4.8 (0.9) compared with 3.6(0.7) ml/kg, P<0.001]. There was no correlation between weightgain between sessions of dialysis and the magnitude of lungwater at the start of dialysis. Lung water decreased (P <0.001)to the level of the control group in response to dialysis. Therewas no correlation between weight loss and reduction in lungwater induced by dialysis. In conclusion, we have verified thepresence of subclinical pulmonary oedema which was removed bydialysis in a group of patients with established renal failure.The variations in lung water cannot be explained by hydrostaticmechanisms alone. 相似文献
79.
STEVEN N. VASLEF LYLE F. MOCKROS KEITH E. COOK RONALD J. LEONARD JEFFREY C. SUNG ROBERT W. ANDERSON 《Artificial organs》1994,18(11):813-817
Abstract: A semiempirical mathematical model of convective oxygen transport is used to design a new, low pressure loss, implantable artificial lung that could be used as a bridge to lung transplantation in patients with advanced respiratory failure. The mass transfer and flow friction relations pertinent to the design of a cross–flow hollow fiber membrane lung are described. The artificial lung is designed to transfer over 200 ml/min of oxygen at blood flow rates up to 5 L/min. A compact design and a blood-side pressure loss of <15 mm Hg allows the device to be implanted in the left chest without the need for a prosthetic blood pump. Surgical implantation of the artificial lung would require the creation of inflow and outflow anastomoses. Oxygen would be supplied via an external source. Blood properties, operating conditions, and empirically determined mass transfer and flow properties are all specified and input into a computer program that numerically solves the design equations. Computer–generated values for the device frontal area, blood path length, and fiber surface area are thereby obtained. The use of this computer–assisted design minimizes the need for extensive trial–and–error testing of prototype devices. Results from in vitro tests of a prototype implantable lung indicate that the mathematical model we describe is an accurate and useful tool in the design of hollow fiber artificial lungs. 相似文献
80.
Alex Y. Chang Z. Nora Tu Julia L. Smith Philip Bonomi Thomas J. Smith Peter H. Wiernik Ronald Blum 《Investigational new drugs》1995,13(2):137-141
Summary Fifty-five patients with metastatic non-small cell lung cancer (NSCLC) were entered into this phase II randomized study for evaluating three new agents: gallium nitrate, amonafide and teniposide. The patients had to have ECOG performance status 0 or 1, no prior chemotherapy, and adequate hematological, hepatic and renal functions. Forty-seven patients were eligible and evaluable. Fourteen were randomized to receive gallium nitrate, 18 to amonafide and 15 to teniposide. Seventy-four percent of eligible patients were male. The majority of patients (89%) had an ECOG performance status 1. ECOG grade 4 toxicity occurred twice in patients on gallium nitrate, seven times on amonafide and 18 times on teniposide. The cause of death was attributed to amonafide in one patient (from sepsis) and to teniposide in two patients (due to infection and leukopenia). There was no objective response in all the patients entered. The overall survival times ranged from 2 weeks to 156 weeks with a median of 23 weeks. There were no survival differences among the three treatment arms. We conclude that gallium nitrate, amonafide and teniposide are inactive in metastatic NSCLC and do not warrant any further testing in this disease.The contents of this study is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute. 相似文献